Delivery Order SPE2DB22D9225-SPE2DB24FR8FK
Award Date
8/5/24
Potential Completion Date
8/6/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for delivery orders of the pharmaceutical product Trikafta 100-50-75 mg/150 mg under a firm fixed-price contract with the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The contract has a ceiling value of $36,637.50 and an ultimate completion date of September 12, 2023. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS...
This federal contract award is for the delivery of Trikafta, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $137,029.08 and a completion date of November 1, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award is for the delivery of Trikafta, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $38,633.14 and a performance period ending on February 21, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $18,488.12 for the pharmaceutical product Trikafta 100-50-75 mg/150 mg. The contract has a period of performance ending on February 27, 2025 and is a firm fixed-price contract. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Trikafta. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. DMS Pharmaceutical Group Inc. is a prime vendor for the DLA's Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans...
This contract award is for the pharmaceutical product Trikafta, which is being provided to the Defense Logistics Agency (DLA) by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA. The IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $18,526.83, is for the delivery of Trikafta, a branded pharmaceutical product, with a period of performance through May 14, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that runs through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the specialized medication Trikafta, with an ultimate completion date of October 17, 2024. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) worth...
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the branded pharmaceutical drug Trikafta, with a completion date of March 26, 2024. The contract is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a separate indefinite delivery contract, SPE2DB, with the DLA valued at up to...